Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Pleiotropic genes in psychiatry: Calcium channels and the stress-related FKBP5 gene in antidepressant resistance.

Fabbri C, Corponi F, Albani D, Raimondi I, Forloni G, Schruers K, Kasper S, Kautzky A, Zohar J, Souery D, Montgomery S, Cristalli CP, Mantovani V, Mendlewicz J, Serretti A.

Prog Neuropsychopharmacol Biol Psychiatry. 2018 Feb 2;81:203-210. doi: 10.1016/j.pnpbp.2017.10.005. Epub 2017 Oct 6.

PMID:
28989100
2.

Neuroplasticity and second messenger pathways in antidepressant efficacy: pharmacogenetic results from a prospective trial investigating treatment resistance.

Fabbri C, Crisafulli C, Calati R, Albani D, Forloni G, Calabrò M, Martines R, Kasper S, Zohar J, Juven-Wetzler A, Souery D, Montgomery S, Mendlewicz J, Serretti A.

Eur Arch Psychiatry Clin Neurosci. 2017 Dec;267(8):723-735. doi: 10.1007/s00406-017-0766-1. Epub 2017 Mar 4.

PMID:
28260126
3.

Polymorphisms in GRIK4, HTR2A, and FKBP5 show interactive effects in predicting remission to antidepressant treatment.

Horstmann S, Lucae S, Menke A, Hennings JM, Ising M, Roeske D, Müller-Myhsok B, Holsboer F, Binder EB.

Neuropsychopharmacology. 2010 Feb;35(3):727-40. doi: 10.1038/npp.2009.180. Epub 2009 Nov 18.

4.

Genome-wide association study of antidepressant response: involvement of the inorganic cation transmembrane transporter activity pathway.

Cocchi E, Fabbri C, Han C, Lee SJ, Patkar AA, Masand PS, Pae CU, Serretti A.

BMC Psychiatry. 2016 Apr 18;16:106. doi: 10.1186/s12888-016-0813-x.

5.

ANK3 and CACNA1C--missing genetic link for bipolar disorder and major depressive disorder in two German case-control samples.

Kloiber S, Czamara D, Karbalai N, Müller-Myhsok B, Hennings J, Holsboer F, Lucae S.

J Psychiatr Res. 2012 Aug;46(8):973-9. doi: 10.1016/j.jpsychires.2012.04.017. Epub 2012 May 29.

PMID:
22647524
6.

FKBP5 genetic variation: association with selective serotonin reuptake inhibitor treatment outcomes in major depressive disorder.

Ellsworth KA, Moon I, Eckloff BW, Fridley BL, Jenkins GD, Batzler A, Biernacka JM, Abo R, Brisbin A, Ji Y, Hebbring S, Wieben ED, Mrazek DA, Weinshilboum RM, Wang L.

Pharmacogenet Genomics. 2013 Mar;23(3):156-66. doi: 10.1097/FPC.0b013e32835dc133.

7.

The role of GRIK4 gene in treatment-resistant depression.

Milanesi E, Bonvicini C, Congiu C, Bortolomasi M, Gainelli G, Gennarelli M, Minelli A.

Genet Res (Camb). 2015 Jul 3;97:e14. doi: 10.1017/S0016672315000142.

PMID:
26139080
8.

The FKBP5 polymorphism rs1360780 influences the effect of an algorithm-based antidepressant treatment and is associated with remission in patients with major depression.

Stamm TJ, Rampp C, Wiethoff K, Stingl J, Mössner R, O Malley G, Ricken R, Seemüller F, Keck M, Fisher R, Gaebel W, Maier W, Möller HJ, Bauer M, Adli M.

J Psychopharmacol. 2016 Jan;30(1):40-7. doi: 10.1177/0269881115620459. Epub 2015 Dec 8.

PMID:
26645208
9.

A study of N-methyl-D-aspartate receptor gene (GRIN2B) variants as predictors of treatment-resistant major depression.

Zhang C, Li Z, Wu Z, Chen J, Wang Z, Peng D, Hong W, Yuan C, Wang Z, Yu S, Xu Y, Xu L, Xiao Z, Fang Y.

Psychopharmacology (Berl). 2014 Feb;231(4):685-93. doi: 10.1007/s00213-013-3297-0. Epub 2013 Oct 11.

PMID:
24114429
10.

Rare copy number variation in treatment-resistant major depressive disorder.

O'Dushlaine C, Ripke S, Ruderfer DM, Hamilton SP, Fava M, Iosifescu DV, Kohane IS, Churchill SE, Castro VM, Clements CC, Blumenthal SR, Murphy SN, Smoller JW, Perlis RH.

Biol Psychiatry. 2014 Oct 1;76(7):536-41. doi: 10.1016/j.biopsych.2013.10.028. Epub 2014 Jan 19.

11.

The FKBP5-gene in depression and treatment response--an association study in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Cohort.

Lekman M, Laje G, Charney D, Rush AJ, Wilson AF, Sorant AJ, Lipsky R, Wisniewski SR, Manji H, McMahon FJ, Paddock S.

Biol Psychiatry. 2008 Jun 15;63(12):1103-10. doi: 10.1016/j.biopsych.2007.10.026. Epub 2008 Jan 11.

12.

Pharmacogenetics in major depression: a comprehensive meta-analysis.

Niitsu T, Fabbri C, Bentini F, Serretti A.

Prog Neuropsychopharmacol Biol Psychiatry. 2013 Aug 1;45:183-94. doi: 10.1016/j.pnpbp.2013.05.011. Epub 2013 Jun 1. Erratum in: Prog Neuropsychopharmacol Biol Psychiatry. 2013 Dec 2;47:118-9.

PMID:
23733030
13.

Influence of BCL2 gene in major depression susceptibility and antidepressant treatment outcome.

Zhang C, Wu Z, Hong W, Wang Z, Peng D, Chen J, Yuan C, Yu S, Xu L, Fang Y.

J Affect Disord. 2014 Feb;155:288-94. doi: 10.1016/j.jad.2013.11.010. Epub 2013 Nov 25.

PMID:
24321200
14.

Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.

Li QS, Tian C, Seabrook GR, Drevets WC, Narayan VA.

Transl Psychiatry. 2016 Sep 13;6(9):e889. doi: 10.1038/tp.2016.171.

15.

FAS -670A>G genetic polymorphism Is associated with Treatment Resistant Depression.

Santos M, Carvalho S, Lima L, Mota-Pereira J, Pimentel P, Maia D, Correia D, Gomes S, Cruz A, Medeiros R.

J Affect Disord. 2015 Oct 1;185:164-9. doi: 10.1016/j.jad.2015.06.027. Epub 2015 Jun 24.

PMID:
26186532
16.

The Impact of BDNF Polymorphisms on Suicidality in Treatment-Resistant Major Depressive Disorder: A European Multicenter Study.

Schosser A, Carlberg L, Calati R, Serretti A, Massat I, Spindelegger C, Linotte S, Mendlewicz J, Souery D, Zohar J, Montgomery S, Kasper S.

Int J Neuropsychopharmacol. 2017 Oct 1;20(10):782-787. doi: 10.1093/ijnp/pyx028.

17.

Early improvement and response to antidepressant medications in adults with major depressive disorder. Meta-analysis and study of a sample with treatment-resistant depression.

Olgiati P, Serretti A, Souery D, Dold M, Kasper S, Montgomery S, Zohar J, Mendlewicz J.

J Affect Disord. 2018 Feb;227:777-786. doi: 10.1016/j.jad.2017.11.004. Epub 2017 Nov 10.

PMID:
29254066
18.

New insights into the pharmacogenomics of antidepressant response from the GENDEP and STAR*D studies: rare variant analysis and high-density imputation.

Fabbri C, Tansey KE, Perlis RH, Hauser J, Henigsberg N, Maier W, Mors O, Placentino A, Rietschel M, Souery D, Breen G, Curtis C, Sang-Hyuk L, Newhouse S, Patel H, Guipponi M, Perroud N, Bondolfi G, O'Donovan M, Lewis G, Biernacka JM, Weinshilboum RM, Farmer A, Aitchison KJ, Craig I, McGuffin P, Uher R, Lewis CM.

Pharmacogenomics J. 2018 May 22;18(3):413-421. doi: 10.1038/tpj.2017.44. Epub 2017 Nov 21.

PMID:
29160301
19.

Neuronal cell adhesion genes and antidepressant response in three independent samples.

Fabbri C, Crisafulli C, Gurwitz D, Stingl J, Calati R, Albani D, Forloni G, Calabrò M, Martines R, Kasper S, Zohar J, Juven-Wetzler A, Souery D, Montgomery S, Mendlewicz J, Girolamo GD, Serretti A.

Pharmacogenomics J. 2015 Dec;15(6):538-48. doi: 10.1038/tpj.2015.15. Epub 2015 Apr 7.

PMID:
25850031
20.

TPH-2 Polymorphisms Interact with Early Life Stress to Influence Response to Treatment with Antidepressant Drugs.

Xu Z, Reynolds GP, Yuan Y, Shi Y, Pu M, Zhang Z.

Int J Neuropsychopharmacol. 2016 Nov 1;19(11). pii: pyw070. doi: 10.1093/ijnp/pyw070. Print 2016 Nov.

Supplemental Content

Support Center